Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |